ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.

Himmelfarb, Marina; Klopocki, Eva; Grube, Susanne; Staub, Eike; Klaman, Irina; Hinzmann, Bernd; Kristiansen, Glen; Rosenthal, André; Dürst, Matthias; Dahl, Edgar

Himmelfarb, Marina; Klopocki, Eva; Grube, Susanne; Staub, Eike; Klaman, Irina; Hinzmann, Bernd; Kristiansen, Glen; Rosenthal, André; Dürst, Matthias; Dahl, Edgar.

Affiliation

Himmelfarb M; metaGen Pharmaceuticals GmbH, Oudenarder Str. 16, 13347 Berlin, Germany.

Cancer Lett ; 204(1): 69-77, 2004 Feb 10.

Article in En | MEDLINE | ID: mdl-14744536

Subject(s)

Breast Neoplasms/genetics; Carrier Proteins/genetics; Amino Acid Sequence; Blotting, Northern; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Carcinoma, Ductal/genetics; Carcinoma, Ductal/metabolism; Carcinoma, Ductal/pathology; Carrier Proteins/metabolism; Cloning, Molecular; DNA, Antisense/pharmacology; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization; Molecular Sequence Data; Neoplasms/genetics; Neoplasms/metabolism; Neoplasms/pathology; Phylogeny; Proteinase Inhibitory Proteins, Secretory; RNA, Messenger/metabolism; Sequence Homology, Amino Acid

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Carrier Proteins Type of study: Prognostic_studies Limits: Humans Language: En Year: 2004 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Carrier Proteins Type of study: Prognostic_studies Limits: Humans Language: En Year: 2004 Type: Article